Spanning research and the clinic: top diabetes awards for Garvan leaders
Three leading diabetes researchers from the Garvan Institute of Medical Research have been announced as the winners of prestigious annual awards bestowed by the Australian Diabetes Society (ADS). The awards will be presented to Professors Mark Febbraio, Jerry Greenfield and Don Chisholm AO at the 2017 Annual Scientific Meeting of the ADS and the Australian Diabetes Educators Association (ADEA) in Perth in August this year.
Professor Mark Febbraio - 2017 ADS Kellion Award
Professor Febbraio will receive the ADS Kellion Award, which is awarded annually by the Kellion Foundation and the ADS, to an Australian who has made an outstanding contribution to diabetes research. Prof Febbraio, who is Head of Garvan’s Diabetes and Metabolism Division, is being recognised for significant advances he has made in deciphering the molecular mechanisms that underlie the protective effects of physical activity, and how they can be used to treat metabolic diseases such as type 2 diabetes. Of particular importance is his pivotal discovery, nearly 15 years ago, that skeletal muscle is an endocrine organ capable of secreting proteins termed ‘myokines’. Prof Febbraio’s ongoing research efforts include pre-clinical and clinical investigations of many identified myokines as personalised treatments for complex metabolic diseases.
As recipient of the award, Prof Febbraio will deliver the ADS Kellion Plenary Lecture at the ADS/ADEA Annual Scientific Meeting.
2017 marks the fourth year that a Garvan researcher has been honoured with this prestigious award; previous recipients include Professor Do Continue reading